Dr. Donnenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
711 Stewart Ave
Garden City, NY 11530Phone+1 516-500-4200Fax+1 516-766-3714- Is this information wrong?
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1984 - 1985
- Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1981 - 1984
- Newton-Wellesley HospitalInternship, Internal Medicine, 1980 - 1981
- Geisel School of Medicine at DartmouthClass of 1980
Certifications & Licensure
- NY State Medical License 1981 - 2026
- CT State Medical License 1999 - 2024
- PA State Medical License 1984 - 1986
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FAAO) American Academy of Ophthalmology
- Top MD Consumers Checkbook
Clinical Trials
- Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK Start of enrollment: 2007 Jan 01
- Artificial Tears Study in Mild to Moderate Dry Eye Patients Start of enrollment: 2007 Jan 01
- Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Pharmacogenomic Analysis of Response to Topical Tumor Necrosis Factor α Antagonist Licaminlimab (OCS-02) in Dry Eye Disease.Eric Donnenfeld, Christophe Baudouin, Anat Galor, Georges Weissgerber, Yunsheng He, Victor L Perez> ;Cornea. 2024 Feb 28
- Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.Shechtman, D., Karpecki, P., Rafieetary, M., Regillo, C., Nijm, L., Kaiser, P., Ryan, E., Ip, M., Yeu, E., Kim, T., Donnenfeld, E.> ;Clinical Ophthalmology. 2024 Jan 1
- 6 citationsLotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).Ian Benjamin Gaddie, Eric D Donnenfeld, Paul Karpecki, Patrick Vollmer, Gregg J Berdy, Jared D Peterson, Blake Simmons, Aimée R P Edell, William E Whitson, Joseph B Ci...> ;Ophthalmology. 2023 Oct 1
- Join now to see all
Press Mentions
- Navigating Through the NoiseJuly 15th, 2022
- Oculis Announces First Patient Enrolled in Phase3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract SurgeryJune 27th, 2022
- New Dry Eye Treatment Technology to Address MGD LaunchesApril 13th, 2022
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- St. Vincent's Medical CenterBridgeport, Connecticut
- Mercy Medical CenterRockville Centre, New York
- Nassau University Medical CenterEast Meadow, New York
- St. Catherine of Siena HospitalSmithtown, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: